High Hopes and Dilemmas for a Cervical Cancer Vaccine

See allHide authors and affiliations

Science  29 Apr 2005:
Vol. 308, Issue 5722, pp. 618-621
DOI: 10.1126/science.308.5722.618

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


As two vaccines against a sexually transmitted virus approach the market, public health experts are debating who should receive them--women, boys, or girls--and how to make them affordable in developing countries where the need is highest.